November 27, 2018
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Mail Stop 4546
Attn: Dorrie Yale
| Re: | CASI Pharmaceuticals, Inc. |
Registration Statement on Form S-3
File No. 333-228383
Request for Acceleration
Ladies and Gentlemen:
CASI Pharmaceuticals, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission accelerate the effective date of its Registration Statement on Form S-3 (File No. 333-228383), so that it may become effective at 4:00 p.m. Eastern Time on November 29, 2018, or as soon thereafter as practicable.
Very truly yours,
CASI PHARMACEUTICALS, INC. | ||
| By: | /s/ Cynthia W. Hu | |
Name: Cynthia W. Hu Title: Chief Operating Officer | ||